IMR Press / CEOG / Volume 25 / Issue 4 / pii/1998049

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Clomiphene citrate challenge test: cycle to cycle variability of cycle day 10 follicle stimulating hormone level

Show Less
1 Department of Obstetrics and Gynecology, American University of Beirut, Medical Centre, Beirut (Lebanon)
Clin. Exp. Obstet. Gynecol. 1998, 25(4), 155–156;
Published: 10 December 1998
Abstract

The clomiphene citrate challenge test (CCCT), a means of assessing ovarian reserve, was shown by several studies to have an excellent predictive value for achieving conception in natural cycles, during ovulation induction and in-vitro fertilization cycles Accordingly we elected to study the cycle to cycle CCCT so as to determine the reliability of a single CCCT result Two groups of patients were studied, the first (n = 40) were those patients who were performing the test because it was indicatedand the second (n = 24) were those who were receiving clomiphene citrate for ovulation induction. In both groups CCCT intercycle variability was significant in 75% of the cases, but this variability altered the prognostic values of the test in only 40% of the first group. In conclusion, our study showed a high percentage of intercycle variability of CCCT but further studies are needed to evaluate the influence of this variability on potential conception.

Keywords
Clomiphene citrate
Follicle stimulating hormone
Share
Back to top